Vancomycin news from FierceHealthcare
NewsNew, lethal MRSA strain emerges
A new strain of methicillin-resistant Staphylococcus aureus (MRSA) is emerging, which poses a grave threat to anyone who contracts it. Researchers with Henry Ford Hospital say the USA600 strain is Read more...
Relapses of clostridium difficile hard to treat
A new study suggests that healthcare professionals aren't happy with the tools they have to fight the growing problem of Clostridium difficile infections in hospitals. C. diff. is a gram-positive Read more...
Use of anti-bacterial drugs increasing
A report in the Archives of Internal Medicine has found that the use of anti-bacterial drugs is increasing, which also increases the risk that bacteria will become resistant to the drugs. The report Read more...
| Press ReleasesDespite Strong Competition from Zyvox, Cubicin and Vibativ, Three-Quarters of Surveyed Infectious Disease Specialists RepoNinety-Two Percent of Surveyed Physicians Say That, if Available, They Would Use Torezolid to Manage Their Patients’ Infections, According to New Report from Arlington Medical Resources EXTON, Pa.--( Read more >> Alexian Brothers Health System Saves More Than $1 Million, Improves Safety with Antimicrobial Stewardship ProgramIllinois health system uses pharmaceutical resources more appropriately with Premier healthcare alliance support CHARLOTTE, N.C.--(BUSINESS WIRE)-- Alexian Brothers Health System of Arlington Read more >> Vancomycin Continues to Dominate MRSA Treatment with up to 76 Percent of Surveyed Infectious Disease Specialists IndicatinApproximately Ten Percent of Inpatients Receiving Antibiotic Treatment Have a Hospital-Acquired Bacterial Infection, According to Findings from Decision Resources and Arlington Medical Resources Read more >> |
